Drug Shortage Report for TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION

Last updated on 2020-01-21 History
Report ID 1664
Drug Identification Number 02412063
Brand name TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION
Common or Proper name TRAVAPROST
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) TRAVOPROST
Strength(s) 0.004%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 5ML
ATC code S01EE
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-02-29
Estimated end date
Actual end date 2019-11-30
Shortage status Resolved
Updated date 2020-01-21
Company comments Item is discontinued
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-01-21 French Compare
v4 2020-01-21 English Compare
v3 2017-03-14 French Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare